Abstract
Recently a new member of the human tumor necrosis factor (TNF) family named as VEGI was reported. However, very little is known about the biological activities displayed by this cytokine. In this report, we show that in myeloid cells VEGI activated the transcription factor κB (NF-κB) as determined by the electrophoretic mobility shift assay, induced degradation of IκBα, and nuclear translocation of p65 subunit of NF-κB. VEGI also activated NF-κB-dependent reporter gene expression. In addition, VEGI activated c-Jun N-terminal kinase. When examined for growth modulatory effects, VEGI inhibited the proliferation of breast carcinoma (MCF-7), epithelial (HeLa), and myeloid (U-937 and ML-1a) tumor cells; and activated caspase-3 leading to PARP cleavage. VEGI-induced cytotoxicity was potentiated by inhibitors of protein synthesis. VEGI also induced proliferation of normal human foreskin fibroblast cells. The activity of VEGI could neither be neutralized by antibodies against TNF, nor could it compete with TNF binding, indicating that the activity of VEGI is not due to TNF and it binds to a distinct receptor. These results suggest that VEGI, a new member of the TNF family, has a signaling pathway similar to TNF and is most likely a multifunctional cytokine.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Abbreviations
- TNF:
-
tumor necrosis factor
- TWEAK:
-
a weak homologue of TNF
- TNANK:
-
TNF homologue that activates NF-κB, JNK and apoptosis
- NF-κB:
-
nuclear transcription factor-κB
- IκB:
-
inhibitory subunit of NF-κB
- IL:
-
interleukin
- EMSA:
-
electrophoretic mobility shift assay
- MAPK:
-
mitogen-activated protein kinase
- VEGI:
-
vascular endothelial cell-derived growth inhibitor
- PARP:
-
poly(A)+ (ADP-ribose) polymerase
- DR3L:
-
death receptor-3 ligand
References
Aggarwal BB. . 1985 Meth. Enzymol. 116: 441–452.
Aggarwal BB and Natarajan K. . 1996 Eur. Cyto. Netw. 7: 93–124.
Baeuerle P and Baltimore D. . 1996 Cell 87: 13–20.
Beutler B and van Huffel C. . 1994 Science 264: 667–668.
Chen YR, Templeton D, Davis RJ and Tan TH. . 1996 J. Biol. Chem. 271: 31929–31936.
Chicheportiche Y, Bourdon PR, Xu H, Hsu YM, Scott H, Hession C, Garcia I and Browning JL. . 1997 J. Biol. Chem. 272: 32401–32410.
Darnay BG and Aggarwal BB. . 1997 J. Leukocyte. Biol. 61: 559–566.
Derijard B, Hibi M, Wu I-H, Barret T, Su B, Karin M and Davis RJ. . 1994 Cell 76: 1025–1029.
Good DJ, Polverini PJ, Rastinejad F, Le Beau MM, Lemons RS, Frazier WA and Bouck NP. . 1990 Proc. Natl. Acad. Sci. USA 87: 6624–6628.
Gruss HJ and Dower SK. . 1995 Blood 85: 3378–3404.
Hahne M, Kataoka T, Schroter M, Hofmann K, Irmler M, Bodmer JL, Schneider P, Bornand T, Holler N, French LE, Sordat B, Rimoldi D and Tschopp J. . 1998 J. Exp. Med. 188: 1185–1190.
Hansen MB, Nielsen SE and Berg K. . 1989 J. Immunol. Meth. 119: 203–210.
Haridas V, Ni J, Meager A, Su J, Yu G-L, Zhai Y, Kyaw H, Akama KT, Hu J, Van Eldik L and Aggarwal BB. . 1998 J. Immunol. 161: 1–6.
Higuchi M and Aggarwal BB. . 1992 Anal. Biochem. 204: 53–57.
Kumar A, Manna SK, Dhawan S and Aggarwal BB. . 1998 J. Immunol. 161: 776–781.
Marsters SA, Sheridan JP, Donahue CJ, Pitti RM, Gray CL, Goddard AD, Bauer KD and Ashkenazi A. . 1996 Curr. Biol. 6: 1669.
Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG and Ware CF. . 1998 Immunity 8: 21–30.
Mazzei GJ, Edgerton MD, Losberger C, Lecoanet-Henchoz S, Graber P, Durandy A, Gauchat JF, Bernard A, Allet B and Bonnefoy JY. . 1995 J. Biol. Chem. 270: 7025–7028.
Mukhopadhyay A, Ni J, Zhai Y, Yu G-L and Aggarwal BB. . 1999 J. Biol. Chem. 274: 15978–15981.
O'Reilly MS, Holmgren L, Shing Y, Chen C, Rosenthal RA, Moses M, Lane WS, Cao Y, Sage EH and Folkman J. . 1994 Cell 79: 315–328.
Pitti RM, Marsters SA, Donahue DJ, Moore A and Ashkenazi A. . 1996 J. Biol. Chem. 271: 12687–12690.
Tan KB, Harrop J, Reddy M, Young P, Emery J, Moore G and Truneh A. . 1997 Gene 204: 35–46.
Tewari M, Quan LT, Rourke KO, Zeng Z, Beidler DR, Salvesen GS and Dixit VM. . 1995 Cell 81: 801–809.
Torigoe K, Ushio S, Okura T, Kobayashi S, Taniai M, Kunikata T, Murakami T, Sanou O, Kojima H, Fujii M, Ohta T, Ikeda M, Ikegami H and Kurimoto M. . 1997 J. Biol. Chem. 272: 25737–25742.
Totpal K, LaPushin R, Kohno T, Darnay BG and Aggarwal BB. . 1994 J. Immunol. 153: 2248–2257.
Schreiber E, Matthias M, Muller M and Schaffner W. . 1989 Nucl. Acids Res. 17: 6419–6422.
Singh S and Aggarwal BB. . 1995a J. Biol. Chem. 270: 10631–10639.
Singh S and Aggarwal BB. . 1995b J. Biol. Chem. 270: 24995–25000.
Smith CA, Farrah T and Goodwin RG. . 1994 Cell 76: 959–962.
Van Lint J, Agostinis P, Vandevoorde V, Haegerman G, Fiers W, Merlevede W and Vandenheede JR. . 1992 J. Biol. Chem. 267: 25916–25921.
Westwick JK, Weitzel C, Minden A, Karin M and Brenner DA. . 1994 J. Biol. Chem. 269: 26396–26401.
Wiley SR, Schooley K, Din WS, Huand C-P, Sutherland GR, Smith CA and Goodwin RG. . 1995 Immunity 3: 673–682.
Wong BR, Arron J, Orlinick J, Kalachikov S, Cayani E, Frankel WN, Lee SY and Choi Y. . 1997 J. Biol. Chem. 272: 25190–25194.
Yue TL, Ni J, Romanic AM, Gu JL, Keller P, Wang C, Kumar S, Yu GL, Hart TK, Wang X, Xia Z, DeWolf Jr WE and Feuerstein GZ. . 1999 J. Biol. Chem. 274: 1479–1486.
Zhai Y, Ni J, Jiang G-W, Lu J, Xing L, Lincoln C, Janat F, Kozak D, Rojas J, Aggarwal BB, Ruben S, Li L, Gentz R and Yu G. . 1999 FASEB J. 13: 181–189.
Acknowledgements
This research was supported by The Clayton Foundation.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Haridas, V., Shrivastava, A., Su, J. et al. VEGI, a new member of the TNF family activates Nuclear Factor-κB and c-Jun N-terminal kinase and modulates cell growth. Oncogene 18, 6496–6504 (1999). https://doi.org/10.1038/sj.onc.1203059
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1203059
Keywords
This article is cited by
-
Regulation of anoikis by extrinsic death receptor pathways
Cell Communication and Signaling (2023)
-
c-Jun N-terminal kinase 2 promotes enterocyte survival and goblet cell differentiation in the inflamed intestine
Mucosal Immunology (2017)
-
Evaluation of 188Re-labeled NGR–VEGI protein for radioimaging and radiotherapy in mice bearing human fibrosarcoma HT-1080 xenografts
Tumor Biology (2016)
-
Human primary biliary cirrhosis-susceptible allele of rs4979462 enhances TNFSF15 expression by binding NF-1
Human Genetics (2015)
-
In vivo NIRF imaging-guided delivery of a novel NGR–VEGI fusion protein for targeting tumor vasculature
Amino Acids (2014)